Atra stock forecast.

Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.

Atra stock forecast. Things To Know About Atra stock forecast.

Aug 8, 2023 · The percentage change in ATRA’s stock price is not provided. Looking ahead, ATRA’s next reporting date is scheduled for August 9, 2023. Analysts forecast an EPS (earnings per share) of -$0.66 for the current quarter. In the previous year, ATRA reported annual revenue of $63.6 million but incurred a net loss of -$228.3 million. Atara Biotherapeutics, Inc. (ATRA) stock forecast and price target. Find the latest Atara Biotherapeutics, Inc. ATRA analyst stock forecast, price target, and recommendation trends with in-depth ...Discover historical prices for ATRA stock on Yahoo Finance. View daily, weekly or monthly format back to when Atara Biotherapeutics, Inc. stock was issued.ATRA forecast by analyst 3. Atara Biotherapeutics stock fundamental checker 4. ATRA social sentiment 5. Analyzing Atara Biotherapeutics (ATRA) Stock Forecast in the …

Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.

16.19 0.00 0.00% The 7 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —. Analyst rating Based on 9 analysts giving stock …Real time Atara Biotherapeutics (ATRA) stock price quote, stock graph, news & analysis.

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comThe Atara Biotherapeutics stock forecast for tomorrow is $ 0.237094, which would represent a -1.21% loss compared to the current price. In the next week, the price of ATRA is expected to increase by 2.28% and hit $ 0.245483. As far as the long-term Atara Biotherapeutics stock forecast is ... Atara Biotherapeutics stock forecast for 18.11.2023. Estimated Average Forecasted Atara Biotherapeutics Price: 1.92 Positive intraday dynamics of the instrument is expected with 2.384% volatility is expected. Pessimistic forecast: 1.89. Optimistic: 1.93. Atara Biotherapeutics stock forecast for 19.11.2023.With the interplay of data, predictions, and real-time performance, Atara Biotherapeutics's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.Dec 1, 2023 · Their ATRA share price targets range from $25.00 to $31.00. On average, they expect the company's stock price to reach $28.00 in the next year. This suggests a possible upside of 4,490.2% from the stock's current price. View analysts price targets for ATRA or view top-rated stocks among Wall Street analysts.

Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.

Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.

With the interplay of data, predictions, and real-time performance, Atara Biotherapeutics's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.6 equities research analysts have issued 12 month target prices for AMC Entertainment's stock. Their AMC share price targets range from $4.75 to $19.00. On average, they predict the company's share price to reach $10.35 in the next year. This suggests a possible upside of 50.9% from the stock's current price.NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52. Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Nov 29, 2023 · Price vs Fair Value. View History. ATRA is trading within a range we consider fairly valued. Price. $0.70. Nov 29, 2023. Fair Value. $1.40. Nov 29, 2023.

Stock Price Forecast. According to 11 stock analysts, the average 12-month stock price forecast for NIO Inc. stock is $12.33, which predicts an increase of 72.45%. The lowest target is $8.00 and the highest is $18. …Oct 27, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comWhat is the current Price Target and Forecast for Atara Biotherapeutics (ATRA) Atara Biotherapeutics (ATRA) (Delayed Data from NSDQ) $0.51 USD +0.03 (6.14%) Updated Nov 17, 2023 04:00 PM ET...7 equities research analysts have issued 12-month price targets for Luminar Technologies' stock. Their LAZR share price targets range from $3.00 to $20.00. On average, they expect the company's stock price to reach $11.71 in the next twelve months. This suggests a possible upside of 376.2% from the stock's current price.

Analyst projections state that ATRA is forecast to be at a low of $1.40 and a high of $31.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2248.48% from its current level, while the stock would need to crash -6.06% from its current level to reach the projected low.According to the issued ratings of 4 analysts in the last year, the consensus rating for Atara Biotherapeutics stock is Hold based on the current 3 hold ratings and 1 buy rating for ATRA. The average twelve-month price prediction for Atara Biotherapeutics is $28.00 with a high price target of $31.00 and a low price target of $25.00.

Real time Atara Biotherapeutics (ATRA) stock price quote, stock graph, news & analysis. 6.1%. 10% most volatile stocks in US Market. 15.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: ATRA is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 29% a week. Volatility Over Time: ATRA's weekly volatility has increased from 18% to 29% over the past year.Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2021 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.Atara Biotherapeutics Inc. Watch list Set a price target alert After Hours Last Updated: Nov 22, 2023 7:55 p.m. EST Delayed quote $ 0.5402 -0.03 -5.56% After Hours Volume: 53.15K Advanced...Dec 3, 2023 · 6.1%. 10% most volatile stocks in US Market. 15.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: ATRA is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 29% a week. Volatility Over Time: ATRA's weekly volatility has increased from 18% to 29% over the past year. ATRA Atara Biotherapeutics (ATRA) Stock Forecast for 2023 – 2026. Sell or Buy? Updated: November 24, 2023 (12:38) Sector: Healthcare The share price of …Find real-time MULN - Mullen Automotive Inc stock quotes, company profile, news and forecasts from CNN Business.1 equities research analysts have issued twelve-month price objectives for Astra Space's stock. Their ASTR share price targets range from $15.00 to $15.00. On average, they anticipate the company's share price to reach $15.00 in the next year. This suggests a possible upside of 971.4% from the stock's current price.Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Akebia Therapeutics Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 4.00. The median ...

It follows that stock’s current price would drop -7268.42% in reaching the projected high whereas dropping to the targeted low would mean a loss of -31.58% for stock’s current value. Atara Biotherapeutics Inc (ATRA) estimates and forecasts

Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...

49 brokerages have issued 1-year target prices for Meta Platforms' stock. Their META share price targets range from $155.00 to $435.00. On average, they anticipate the company's share price to reach $349.53 in the next year. This suggests a possible upside of 3.3% from the stock's current price.Find real-time ZVRA - Zevra Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...This rich reservoir of information aids in informed decision-making, blending historical data with future predictions to paint a holistic picture of stock performance trajectories. …T Stock 12 Months Forecast. Based on 15 Wall Street analysts offering 12 month price targets for AT&T in the last 3 months. The average price target is $19.82 with a high forecast of $28.00 and a low forecast of $16.00. The average price target represents a 26.81% change from the last price of $15.63.According to 11 Wall Street analyst s that have issued a 1 year T price target, the average T price target is $18.32, with the highest T stock price forecast at $22.00 and the lowest T stock price forecast at $14.00. On average, Wall Street analysts predict that AT&T 's share price could reach $18.32 by Oct 23, 2024.15 analysts have issued 12-month price objectives for Boeing's stock. Their BA share price targets range from $200.00 to $300.00. On average, they expect the company's stock price to reach $249.38 in the next year. This suggests a possible upside of 13.4% from the stock's current price.Find real-time PLTR - Palantir Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.allforecast.comWhat is the current Price Target and Forecast for Atara Biotherapeutics (ATRA) Atara Biotherapeutics (ATRA) (Delayed Data from NSDQ) $0.51 USD +0.03 (6.14%) Updated Nov 17, 2023 04:00 PM ET...During the last day, the stock moved $0.0269 between high and low, or 3.59%. For the last week the stock has had daily average volatility of 2.76% . Our recommended stop-loss: $0.740 (-4.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 46 days ago.)Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...

Rivian Automotive Stock Forecast 12-07-2023. Forecast target price for 12-07-2023: $ 18.63. Negative dynamics for Rivian Automotive shares will prevail with possible volatility of 5.691%. Pessimistic target level: 18.06. Optimistic target level: 19.15.Find the latest Atlas Lithium Corporation (ATLX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Jun 30, 2023 · ATRA stock forecast for 2023 – 2027. Last updated: January 22, 2023. ATRA. Atara Biotherapeutics, Inc. 3.89 D 9.58% (0.34) Are you interested in Atara Biotherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATRA stock price in 2022-2027. Is ATRA a good long term stock? Instagram:https://instagram. permian basin royalty trustbeaconpointesolar energy stockssekur private data Atara Biotherapeutics to Participate at the 6th Annual Evercore ISI HealthCONx Conference. Nov 10, 2023 4:01 pm EST.Nov 23, 2023 · High Growth Earnings: ATRA is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ATRA's revenue (44.8% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: ATRA's revenue (44.8% per year) is forecast to grow faster than 20% per year. dividend ex datesbeyond burger costco ATRA stock forecast Our latest prediction for Atara Biotherapeutics Inc's stock price was made on the Aug. 21, 2023 when the stock price was at 1.41$. In the short term (2weeks), ATRA's stock price should underperform the market by -2.71%. During that period the price should oscillate between -13.09% and +13.51%. how to get a mortgage without tax returns ZIM Integrated Shipping Services (NYSE:ZIM) pays an annual dividend of $9.35 per share and currently has a dividend yield of 134.73%. ZIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for ZIM.10 Wall Street research analysts have issued 1-year price objectives for Rogers Communications' stock. Their RCI.B share price targets range from C$54.00 to C$90.00. On average, they anticipate the company's share price to reach C$71.58 in the next twelve months. This suggests a possible upside of 21.9% from the stock's current …